Keywords: liver cirrhosis, alcoholic, cause of death, coronary disease, atherosclerosis


Background. Alcohol is considered to be the main risk factor for adverse event deaths around the world. In Ukraine, mortality due to alcoholic liver disease (ALD) has taken the second place in the structure of death causes from diseases of the digestive system.

Objective. The aim of the research was to study the peculiarities of the causes of death in the patients with alcoholic liver disease at the stage of liver cirrhosis (LC) based on the analysis of protocols of pathoanatomical research.

Methods. The analysis of 149 protocols of the pathoanatomical study of the patients, who died from alcoholic LC, has been carried out at the premises of the Pathoanatomical Department of the Ivano-Frankivsk Regional Clinical Hospital in 2006-2018.

Results. Most people were young and middle aged. Fatal cases were caused by decompensation of the LC with the development of hepatic, hepatic-renal, cardio-pulmonary insufficiency, pancreatic necrosis, gastrointestinal bleeding (GIB), sepsis, hepatocellular carcinoma (HCC). In 37.6 % of the patients the concomitant illness was coronary heart disease (CHD), 10.7 % of the people had hypertension. In 6 % of the patients, ischemic stroke of the brain was diagnosed. In most people atherosclerotic vascular changes were revealed.

Conclusions. Excessive consumption of alcohol and, consequently, the development of LC, can be considered as an adverse factor in the reducing social standard of living. In the majority of people, who died from the decompensation of alcoholic LC, atherosclerotic vascular lesions have been detected. This indicates a significant prevalence of lipid metabolism disturbance in the people with alcoholic LC.

Author Biography


MD, Ph.D, Assosiate Professor of the Department of Therapy and Family

Practice of postgraduate study faculty, Ivano-Frankivsk National Medical University,

16 Kropyvnytskyi str., Ivano-Frankivsk, 76018.

ORCID 0000-0002-9924-2127


Melnyk PS, Slabkyi HO, Dziuba OM, Chepelev­ska LA, Kudrenko MV. Annual report on the health status of the population, the sanitary and epide­miological situation and the results of the Ukrainian health care system, 2016. Kyiv: Ministry of health of Ukraine, GA “Ukrainian Institute of Strategic Studies Ministry of Health of Ukraine”. 2017;516 [In Ukrai­nian]. Available at:

Sherstiuk NS, Sokolov AV. Health of Ukraine’s population and its impact on the demographic situation. Economics and Society. 2016;5:316-19 [In Ukrainian]. Available at:

Parkheta LV. Medical demographic indicators and their impact on the development of voluntary health insurance in Ukraine. Effective economy. 2018;1 [In Ukrainian]. Available at:

Chepelevska LA, Dziuba OM, Kruchanytsia VV. Regional peculiarities of mortality of the population of Ukraine from fibrosis and cirrhosis of the liver and alcoholic liver disease. Ukraine. The health of the nation. 2016;4/1(41):218-23 [In Ukrainian]. Available at:

Ruiz-Margáin A, Macías-Rodríguez RU, Ríos-Torres SL, Román-Calleja BM, Méndez-Guerrero O, Rodríguez-Córdova P, et al. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of pa­tients with cirrhosis. Rev Gastroenterol Mex. 2018;83:9. doi: 10.1016/j.rgmxen.2017.02.005

Ali Mokdad A, Lopez АD, Shahraz S, Lozano R, Ali Mokdad H, Stanaway J et. al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine 2014;12:145. doi: 10.1186/s12916-014-0145-y

Nilsson E, Anderson H, Sargenti K, Lindgren S, Prytz H. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year populationbased study. Aliment Pharmacol Ther 2016 Jun; 43(12):1330-9. doi: 10.1111/apt.13635

Osodlo HV. Epidemiological and therapeutic aspects of chronic diffuse liver disease in military personnel. Gastroenterology. 2013;4(50):50-6 [In Ukrainian]. Available at:

Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug and Alcohol Review. 2010 Jul; 29(4):437-45. doi: 10.1111/j.1465-3362.2009.00153.x

Schiavo L, Busetto L, Cesaretti M, Zelber-Sagi Sh, Deutsch L, Iannelli A. Nutritional issues in patients with obesity and cirrhosis. World J Gastroenterol. 2018;24(30):3330-3346. doi: 10.3748/wjg.v24.i30.3330

Chepelevska LA, Krapivina AA. Features of the mortality rate of the population of Ukraine from individual diseases of the digestive system. Ukraine. The health of the nation. 2013; 1 (25): 54-8 [In Ukrainian]. Available at:

Allen A. M., Kim W. R. Epidemiology and healthcare burden of acute-on-chronic liver failure. Sem Liv Dis 2016 May;36(2):123-6. doi: 10.1055/s-0036-1583201

Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016; 51:629-650. doi: 10.1007/s00535-016-1216-y

Chen H, Zhang Y, Li S, Li N , Chen Y, Zhang B. Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Manag Res. 2018;10:1947-1958. doi: 10.2147/CMAR.S167036

Fialla AD, Israelsen M, Hamberg O, Krag A, Gluud LL. Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis. Liver Int. 2015; 35:2072-2078. doi: 10.1111/liv.12798

Garbuzenko D, Arefyev N, Kazachkov E. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol. 2018;24(33):3738-3748. doi: 10.3748/wjg.v24.i33.3738

How to Cite
Matkovska, N. R. (2019). MORTALITY ANALYSIS OF THE PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS. International Journal of Medicine and Medical Research, 5(1), 40-46.